| Name | Title | Contact Details |
|---|
Ophelia is a digital provider of medication-assisted treatment (MAT) for opioid use disorder (OUD), committed to making evidence-based treatment universally accessible. Its mission is to remove barriers for the 80% of Americans with OUD who are unable to access care and the 50,000+ MAT-licensed clinicians who are unable to treat patients due to a lack of infrastructure, training, and support. At its core is the Ophelia Care Model, a team-based clinical model and software platform developed by leading experts in addiction medicine and psychiatry. Ophelia is licensed to provide care in 36 states and contracted with Medicaid, Medicare, and Commercial insurers covering 85 million American lives.
Residence XII is a Kirkland, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Long Island Consultation Center is a Rego Park, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
FOI Services is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Audible Difference is a Madison, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.